Skip to main content
. 2004 Apr 1;6(3):93–97. doi: 10.1186/ar1172

Figure 1.

Figure 1

Representative synovial tissue before and after specific CC chemokine receptor (CCR)1 blockade for 14 days in a patient with rheumatoid arthritis (haematoxylin–eosin staining; original magnification × 400). After active treatment there was a marked reduction in synovial cellularity, which was not observed in patients who received placebo. The reduction in cell infiltration was due to a specific decrease in CCR1-positive cells [29].